PK assessors variability [Bioanalytics]

posted by Obinoscopy  – USA, 2020-07-17 23:48 (186 d 14:50 ago) – Posting: # 21735
Views: 2,346

Hi Ohlbe,

» In Europe: add the between-country variability. In the US: possibly a between-review-division variability ?

:-D

I wonder the study design we can use to measure these variabilities...especially the variability within the USFDA.

But this is sad...I had thought standardization and uniformity of regulatory review methods should be one of the foundation of regulatory science.

Scopy

Complete thread:

Activity
 Admin contact
21,308 posts in 4,444 threads, 1,489 registered users;
online 12 (0 registered, 12 guests [including 4 identified bots]).
Forum time: Wednesday 13:38 CET (Europe/Vienna)

Power: That which is wielded by the priesthood of
clinical trials, the statisticians, and a stick which they use
to beta their colleagues.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5